⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 12, 2014Journal of Clinical Gastroenterology

Outpatient Ulcerative Colitis Primary Anti-TNF Responders Receiving Adalimumab or Infliximab Maintenance Therapy Have Similar Rates of Secondary Loss of Response

Christopher Ma Vivian Huang Darryl K. Fedorak Karen I. Kroeker Levinus A. Dieleman Brendan P. Halloran Richard N. Fedorak

View at Publisher

Ask AI

Bookmark

Share

Abstract

In this real-life cohort of anti-TNF-naive primary responders with UC, the proportion of secondary loss of response and the time to secondary loss of response are similar for adalimumab and infliximab.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ma et al. (2014) studied this question.

synapsesocial.com/papers/69d7f57e7392c8ce61bee490 https://doi.org/10.1097/mcg.0000000000000265

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Efficacy of adalimumab for the management of Inflammatory Bowel Disease in the Clinical SettingCohort Study · 2009 · 35 citations
2Distributed Sample Allocation for the Diagnosis of Mass Lesions by EUS-FNAJournal of Clinical Gastroenterology · Mon,
3Metabolic Syndrome Is Associated With Worsened Clinical Outcomes in Individuals With Necrotizing PancreatitisJournal of Clinical Gastroenterology · Fri,
4The Burden of Early-Onset Gastric Cancer From 1990 to 2021Journal of Clinical Gastroenterology · Wed,
5High-Resolution Manometry Assessment of Esophagitis Across Los Angeles Grades Validates Lyon 2.0 CriteriaJournal of Clinical Gastroenterology · Mon,

More from Journal of Clinical Gastroenterology

Comparison of the Efficacy of Dexrabeprazole and Rabeprazole in Inhibiting Intragastric and Intraesophageal Acidity in Gastroesophageal Reflux DiseaseMon,
The Trajectory of Gastrointestinal Symptom Experience Following Fecal Microbiota Transplant for Recurrent Clostridioides Difficile InfectionFri,
Monoclonal Antibody Therapy in Eosinophilic EsophagitisFri,
Patient Satisfaction and Perceived Stress in Digestive EndoscopyTue,
Trends and Projections of Esophageal Cancer Incidence and Mortality in China, 1990 to 2050Tue,